Simple blood test could save babies from unnecessary antibiotics
NCT ID NCT06618989
First seen May 03, 2026 · Last updated Jun 23, 2026 · Updated 6 times
Summary
This pilot study tests a new blood test that looks at markers on white blood cells to tell if a feverish baby under 3 months has a serious bacterial infection. Researchers will collect an extra small blood sample from 180 infants in the emergency department. The goal is to see if this test can accurately predict infection, helping doctors decide who truly needs antibiotics and who can go home safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN UNDER 3 MONTHS OF AGE WITH FEVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sorbonne University, pediatric emergency department, Trousseau hospital
RECRUITINGParis, France, 75012, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
hospitalpediatric emergency department, Trousseau hospital
NOT_YET_RECRUITINGParis, 75012, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Blood test measuring leukocyte cell surface markers
What this could lead to
If successful, this blood test could help doctors quickly identify which febrile infants need antibiotics and which do not, reducing unnecessary hospital stays and treatments.
What could go wrong
This is a small pilot study with only 180 infants, so results may not be definitive. The test is still experimental and may not work as well in real-world settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.